Company news
Lifeward Ltd. news in 2026
Lifeward Ltd.'s news releases, calls and decks from 2026, newest first.
Lifeward’s ReWalk® Personal Exoskeleton Demonstrates Sustained Long-Term Home Use and Patient Satisfaction in Latest Independent Peer-Reviewed Study
October 14, 2026
Lifeward Publishes Updated Investor Presentation Highlighting Commercial Growth Strategy
September 8, 2026
Lifeward Appoints Josh Hexter Interim Chief Executive Officer and Rami Aviram Chief Financial Officer
August 31, 2026
Lifeward Reports Strong Second Quarter 2026 Financial Results as Commercial Execution Drives Growth
August 14, 2026
Lifeward to Report Second Quarter 2026 Financial Results on August 14, 2026
August 7, 2026
Lifeward Launches Pilot Program with Ottobock Care to Expand National Access to ReWalk® Personal Exoskeleton
August 5, 2026
Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic Financing
July 7, 2026
Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed Platform
May 18, 2026
Lifeward Reports First Quarter 2026 Financial Results
May 14, 2026
Lifeward to Report First Quarter 2026 Financial Results on May 15, 2026
May 11, 2026
Lifeward Announces New ReWalk® Data Presented at ASIA 2026 Conference Demonstrating a Comprehensive Longitudinal Safety Analysis for a Powered Exoskeleton
May 4, 2026
Lifeward Successfully Closes on Strategic Partnership with Oramed
March 25, 2026
Lifeward Reports Fourth Quarter and Full Year 2025 Financial Results
March 18, 2026
Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical Company
March 13, 2026
Lifeward Regains Compliance with Nasdaq Minimum Bid Price Requirement
March 11, 2026
Lifeward to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026
March 9, 2026
Lifeward Announces Collaboration With Shirley Ryan AbilityLab to Expand Access for the ReWalk Personal Exoskeleton
March 1, 2026
Lifeward to Acquire Powered Upper Body Exoskeleton with AI Capabilities Designed to Restore Function to Stroke Survivors
February 24, 2026
Lifeward Announces Reverse Share Split
February 20, 2026
Lifeward’s ReWalk™ Personal Exoskeleton Now Covered by Aetna, Coverage Expands to Include Three of the Largest Medicare Advantage Insurers
February 17, 2026
Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company
January 13, 2026
Calls in 2026
Decks in 2026
- Investor Presentation (September 2026)
Investor deck · 17 slides · September 2026